Image
- Cancer Care Team
Cancer Care Team
To deliver optimal patient outcomesProducts and Services
Cancer Type
Supplies & Tools
Scientific Focus
- Biopharma Partners
- Patients
- Education & Events
- Login
- Contact Us
Event
Personalized medicine depends on a strong diagnostics industry, which faces an uncertain future. This panel examines the perspectives of investors and senior executives on the financial future of the industry.
MODERATOR | Michael D. Goldberg, Executive Chairman, DNAnexus, Chairman, CareDx
Brian Caveney, M.D., Chief Medical & Scientific Officer, Labcorp
Michael Pellini, M.D., General Partner, S32
Sam Raha, Chief Operating Officer, Myriad Genetics
Matthew Sykes, Managing Director, Life Sciences and Diagnostics Industry Investments, Goldman Sachs